Physician profile
Julia E Pierce
NPI 1811425705
$3,063.14
in general payments reported to CMS, 2019-2025
18 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $57.35 · 2021: $522 · 2022: $610 · 2023: $534 · 2024: $876 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,236.46 | 2019-2025 | Clareon, Precision 1, Dailies Total1 |
| Glaukos Corporation | $426.36 | 2022-2025 | Photrexa, Ce-Marked Kxla System, Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $337.68 | 2024-2025 | Xdemvy |
| Rxsight INC | $228.86 | 2022-2024 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Dompe US, INC. | $161.57 | 2019-2024 | Oxervate |
| Biotissue Holdings INC. | $113.69 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $108.05 | 2023-2024 | Miebo, Xiidra, Vyzulta |
| Coopervision INC. | $103.99 | 2024 | Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $67.04 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55.23 | 2020-2022 | |
| Oyster Point Pharma, INC. | $51.33 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $39.36 | 2023 | |
| Kala Pharmaceuticals, INC. | $36.72 | 2019-2021 | |
| Harrow Eye, LLC | $25.47 | 2025 | Vevye |
| Thea Pharma INC. | $19.47 | 2024 | Iyuzeh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $17.37 | 2022 | |
| Sun Pharmaceutical Industries INC. | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.